Literature DB >> 34017065

Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification.

Ashley B Grossman1,2,3,4, Shereen Ezzat5, Sylvia L Asa6, Ozgur Mete7, Michael D Cusimano8, Ian E McCutcheon9, Arie Perry10, Shozo Yamada11, Hiroshi Nishioka12, Olivera Casar-Borota13, Silvia Uccella14, Stefano La Rosa15.   

Abstract

The classification of adenohypophysial neoplasms as "pituitary neuroendocrine tumors" (PitNETs) was proposed in 2017 to reflect their characteristics as epithelial neuroendocrine neoplasms with a spectrum of clinical behaviors ranging from small indolent lesions to large, locally invasive, unresectable tumors. Tumor growth and hormone hypersecretion cause significant morbidity and mortality in a subset of patients. The proposal was endorsed by a WHO working group that sought to provide a unified approach to neuroendocrine neoplasia in all body sites. We review the features that are characteristic of neuroendocrine cells, the epidemiology and prognosis of these tumors, as well as further refinements in terms used for other pituitary tumors to ensure consistency with the WHO framework. The intense study of PitNETs has provided information about the importance of cellular differentiation in tumor prognosis as a model for neuroendocrine tumors in different locations.
© 2021. The Author(s), under exclusive licence to United States & Canadian Academy of Pathology.

Entities:  

Mesh:

Year:  2021        PMID: 34017065     DOI: 10.1038/s41379-021-00820-y

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  179 in total

Review 1.  Pituitary development: regulatory codes in mammalian organogenesis.

Authors:  Kathleen M Scully; Michael G Rosenfeld
Journal:  Science       Date:  2002-03-22       Impact factor: 47.728

2.  High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.

Authors:  Adrian F Daly; Martine Rixhon; Christelle Adam; Anastasia Dempegioti; Maria A Tichomirowa; Albert Beckers
Journal:  J Clin Endocrinol Metab       Date:  2006-09-12       Impact factor: 5.958

Review 3.  Endocrine pathology: past, present and future.

Authors:  Sylvia L Asa; Ozgur Mete
Journal:  Pathology       Date:  2017-11-11       Impact factor: 5.306

4.  The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas.

Authors:  Hiroshi Nishioka; Naoko Inoshita; Ozgur Mete; Sylvia L Asa; Kyohei Hayashi; Akira Takeshita; Noriaki Fukuhara; Mitsuo Yamaguchi-Okada; Yasuhiro Takeuchi; Shozo Yamada
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

Review 5.  The APUD cell concept and its implications in pathology.

Authors:  A G Pearse
Journal:  Pathol Annu       Date:  1974

6.  INSM1 Expression Is Frequent in Primary Central Nervous System Neoplasms but Not in the Adult Brain Parenchyma.

Authors:  Heather M Ames; Lisa M Rooper; John J Laterra; Charles G Eberhart; Fausto J Rodriguez
Journal:  J Neuropathol Exp Neurol       Date:  2018-05-01       Impact factor: 3.685

7.  INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms.

Authors:  Jason N Rosenbaum; Zhenying Guo; Rebecca M Baus; Helen Werner; William M Rehrauer; Ricardo V Lloyd
Journal:  Am J Clin Pathol       Date:  2015-10       Impact factor: 2.493

Review 8.  The prevalence of pituitary adenomas: a systematic review.

Authors:  Shereen Ezzat; Sylvia L Asa; William T Couldwell; Charles E Barr; William E Dodge; Mary Lee Vance; Ian E McCutcheon
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

9.  Gastric gel mucus thickness: effect of distention, 16,16-dimethyl prostaglandin e2, and carbenoxolone.

Authors:  M Bickel; G L Kauffman
Journal:  Gastroenterology       Date:  1981-04       Impact factor: 22.682

Review 10.  Histopathology of Parasellar Neoplasms.

Authors:  Emilija Manojlovic-Gacic; Elham Rostami; Niki Karavitaki; Olivera Casar-Borota
Journal:  Neuroendocrinology       Date:  2020-03-11       Impact factor: 4.914

View more
  5 in total

1.  Multiple tumorous lesions of the pituitary gland.

Authors:  Jannik von Schöning; Jörg Flitsch; Dieter K Lüdecke; Rudolf Fahlbusch; Michael Buchfelder; Rolf Buslei; Ulrich J Knappe; Markus Bergmann; Walter J Schulz-Schaeffer; Jochen Herms; Markus Glatzel; Wolfgang Saeger
Journal:  Hormones (Athens)       Date:  2022-08-10       Impact factor: 3.419

2.  Single-cell transcriptome and genome analysis: A much-needed tool for pituitary neuroendocrine tumor studies.

Authors:  Sylvia L Asa; Ozgur Mete
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 13.029

Review 3.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms.

Authors:  Ozgur Mete; Bruce M Wenig
Journal:  Head Neck Pathol       Date:  2022-03-21

4.  Pituitary corticotroph tumour with adrenocortical cells: A distinct clinicopathologic entity with unique morphology and methylation profile.

Authors:  Richard A Hickman; John T Gionco; Phyllis L Faust; Michael L Miller; Jeffrey Bruce; Gabrielle Page-Wilson; Marc K Rosenblum; Sylvia L Asa
Journal:  Neuropathol Appl Neurobiol       Date:  2021-08-09       Impact factor: 6.250

Review 5.  Architects of Pituitary Tumour Growth.

Authors:  Maria Eugenia Sabatino; Ezequiel Grondona; Ana Lucía De Paul
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.